Marc Fischer

Title: Marc Fischer: Innovator in Depression Treatment

Introduction

Marc Fischer is a notable inventor based in Pratteln, Switzerland. He has made significant contributions to the field of mental health through his innovative approaches to treating depression. With a total of 4 patents, Fischer's work focuses on the development of oral dosage forms of ketamine for therapeutic use.

Latest Patents

Fischer's latest patents include a "Method for treatment of depression with oral dosage forms of ketamine." This invention relates to an oral dosage form for the administration of ketamine and outlines a method for preparing this dosage form, preferably to be taken once or twice a day. Another significant patent is the "Method for treating depression," which addresses treatment for patients with depression and bipolar disorder who have not responded to traditional antidepressants. This method also aims to prevent dose dumping upon ingestion of alcohol, further enhancing the safety and efficacy of the treatment.

Career Highlights

Throughout his career, Marc Fischer has worked with reputable companies such as Develco Pharma Schweiz AG and Ketabon GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations, particularly in the realm of mental health treatments.

Collaborations

Fischer has collaborated with professionals like Sascha Manthei and Helene Rey, contributing to the advancement of his research and the development of his patents.

Conclusion

Marc Fischer's innovative work in the treatment of depression through oral dosage forms of ketamine showcases his commitment to improving mental health therapies. His contributions are paving the way for more effective treatment options for patients in need.